Literature DB >> 23853193

Severe eyelid oedema in Graves' ophthalmopathy.

Panagiotis Anagnostis1, Fotini Adamidou, Maria Poulasouchidou, Spyridon Karras.   

Abstract

We report a case of severe eyelid oedema due to Graves' ophthalmopathy (GO). The aim was to present a case report and review of the literature about eyelid oedema due to GO. The case report includes a history of patient data and literature review. The patient was offered intravenous methylprednisolone and gave consent. A dosage of 500 mg intravenous methylprednisolone once weekly for 6 weeks, followed by 250 mg intravenous methylprednisolone once weekly for 6 weeks, with a total treatment period of 12 weeks was given. Up to day, minor improvement has been observed. Severe eyelid oedema due to GO is a rare manifestation of Graves' disease. In cases of active and moderate-to-severe disease, treatment with intravenous glucorticoids is recommended alone or with orbital radiotherapy, followed by rehabilitative surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23853193      PMCID: PMC3736300          DOI: 10.1136/bcr-2013-010305

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

Authors:  Luigi Bartalena; Lelio Baldeschi; Alison Dickinson; Anja Eckstein; Pat Kendall-Taylor; Claudio Marcocci; Maarten Mourits; Petros Perros; Kostas Boboridis; Antonella Boschi; Nicola Currò; Chantal Daumerie; George J Kahaly; Gerasimos E Krassas; Carol M Lane; John H Lazarus; Michele Marinò; Marco Nardi; Christopher Neoh; Jacques Orgiazzi; Simon Pearce; Aldo Pinchera; Susanne Pitz; Mario Salvi; Paolo Sivelli; Matthias Stahl; Georg von Arx; Wilmar M Wiersinga
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

Review 2.  Clinical practice. Graves' ophthalmopathy.

Authors:  Luigi Bartalena; Maria Laura Tanda
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

  2 in total
  1 in total

Review 1.  Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?

Authors:  P Anagnostis; K Boboridis; F Adamidou; M Kita
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.